Reviva Pharmaceuticals New Treatment for Schizophrenia
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=V_aBWDY0pbA
We speak with Reviva Pharmaceuticals CEO Dr. Laxaminarayan Bhat about its development of atypical antipsychotic Brilaroxazine for schizophrenia. Schizophrenia affects ~3 million in the US and over 20 million around the globe and lacks a drug with a sufficient balance of efficacy and side effects to limit unwanted discontinuation. • How is Brilaroxazine different from other commonly prescribed agents for schizophrenia? • What is the unmet need in schizophrenia? • Our second video: • • Reviva Pharmaceuticals (RVPH) Active ... • Our third video: • • Reviva Pharmaceuticals: Brilaroxazine... • See our initiation here: • https://s27.q4cdn.com/906368049/files... • and our latest report here: • https://s27.q4cdn.com/906368049/files...
#############################
